Meridian Bioscience (Meridian Bioscience) FCF Margin % : -2.27% (As of Sep. 2022)

View and export this data going back to 1986. Start your Free Trial

What is Meridian Bioscience FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Meridian Bioscience's Free Cash Flow for the three months ended in Sep. 2022 was $-1.5 Mil. Meridian Bioscience's Revenue for the three months ended in Sep. 2022 was $65.7 Mil. Therefore, Meridian Bioscience's FCF Margin % for the quarter that ended in Sep. 2022 was -2.27%.

As of today, Meridian Bioscience's current FCF Yield % is 0.00%.

The historical rank and industry rank for Meridian Bioscience's FCF Margin % or its related term are showing as below:

VIVO' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 22.14
Current: 22.14

During the past 13 years, the highest FCF Margin % of Meridian Bioscience was 22.14%. The lowest was 0.00%. And the median was 0.00%.

VIVO's FCF Margin % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -11.09 vs VIVO: 22.14

Meridian Bioscience FCF Margin % Historical Data

The historical data trend for Meridian Bioscience's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meridian Bioscience FCF Margin % Chart

Meridian Bioscience Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

FCF Margin %

Get a 7-Day Free Trial

14.32

16.11

17.61

15.27

22.14

Meridian Bioscience Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
FCF Margin %	Get a 7-Day Free Trial															16.50	38.31	26.02	18.36	-2.27

Competitive Comparison of Meridian Bioscience's FCF Margin %

For the Diagnostics & Research subindustry, Meridian Bioscience's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meridian Bioscience's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Meridian Bioscience's FCF Margin % falls into.

Meridian Bioscience FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Meridian Bioscience's FCF Margin for the fiscal year that ended in Sep. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Sep. 2022 )	/	Revenue (A: Sep. 2022 )
	=	73.746	/	333.018
	=	22.14 %

Meridian Bioscience's FCF Margin for the quarter that ended in Sep. 2022 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2022 )	/	Revenue (Q: Sep. 2022 )
	=	-1.49	/	65.675
	=	-2.27 %

Meridian Bioscience FCF Margin % Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Meridian Bioscience (Meridian Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Meridian Bioscience Inc (NAS:VIVO) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3471 River Hills Drive, Cincinnati, OH, USA, 45244

Website

https://www.meridianbioscience.com

Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.

Executives

Julie Diana Smith	officer: Sr VP, Controller, PAO	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
John P. Kenny	director, officer: Chief Executive Officer	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Andrew S. Kitzmiller	officer: EVP & CFO	ONE BATESVILLE BLVD., BATESVILLE IN 47006
Bryan T Baldasare	officer: Interim CFO & Chief Acctg Off	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Rice John Mccune Jr.	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Bihl Anthony P Iii	director	807 SMITH RIDGE ROAD, NEW CANAAN CT 06840
Tony Serafini-lamanna	officer: Executive VP-Diagnostics	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Felicia Williams	director	C/O MACY'S, INC., 151 WEST 34TH STREET, NEW YORK NY 10001
John Mcilwraith	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
David Phillips	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
James M. Anderson	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Dwight E Ellingwood	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Lawrence Baldini	officer: Exec VP, Operations & IS	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Eric S. Rasmussen	officer: EVP, Bus. Development/Strategy	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Lourdes Weltzien	officer: EVP, Life Science	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244